![Matthew Notarianni](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Notarianni
Investor Relations Contact at
CERUS CORPORATION
Profile
Matthew Notarianni currently works at Cerus Corp., as Senior Director-Investor Relations and MiMedx Group, Inc., as Head-Investor Relations from 2022.
Mr. Notarianni received his undergraduate degree from Marquette University.
Matthew Notarianni active positions
| Companies | Position | Start |
|---|---|---|
| CERUS CORPORATION | Investor Relations Contact | - |
| MIMEDX GROUP, INC. | Investor Relations Contact | 04/10/2022 |
Training of Matthew Notarianni
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
14
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Cerus Corp.
 Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
Marquette University
 Marquette University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MiMedx Group, Inc.
 MiMedx Group, Inc. Medical SpecialtiesHealth Technology Develops, manufactures, and markets patent protected regenerative biomaterial products and bioimplants | Health Technology |
- Stock Market
- Insiders
- Matthew Notarianni
